Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,610 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial.
Yu J, Jiang L, Zhao L, Yang X, Wang X, Yang D, Zhuo M, Chen H, Huang W, Zhu Z, Zhang M, Song Y, Li Q, Ma Z, Wang Q, Qu Y, Yu R, Yu H, Zhao J, Shi A; Trial Management Group. Yu J, et al. Among authors: ma z. Lancet Respir Med. 2024 Oct;12(10):799-809. doi: 10.1016/S2213-2600(24)00189-9. Epub 2024 Aug 12. Lancet Respir Med. 2024. PMID: 39146944 Clinical Trial.
Treatment optimization of pelvic external beam radiation and/or vaginal brachytherapy for patients with stage I to II high-risk Endometrioid adenocarcinoma: a retrospective multi-institutional analysis.
Wang W, Zou L, Wang T, Liu Z, He J, Sun X, Zhong W, Zhao F, Li X, Li S, Zhu H, Ma Z, Sun S, Jin M, Zhang F, Hou X, Wei L, Hu K. Wang W, et al. Among authors: ma z. BMC Cancer. 2021 Jul 4;21(1):774. doi: 10.1186/s12885-021-08524-x. BMC Cancer. 2021. PMID: 34217240 Free PMC article.
Utilization Trend and Comparison of Different Radiotherapy Modes for Patients with Early-Stage High-Intermediate-Risk Endometrial Cancer: A Real-World, Multi-Institutional Study.
Ren K, Zou L, Wang T, Liu Z, He J, Sun X, Zhong W, Zhao F, Li X, Li S, Zhu H, Ma Z, Sun S, Wang W, Hu K, Zhang F, Hou X, Wei L. Ren K, et al. Among authors: ma z. Cancers (Basel). 2022 Oct 19;14(20):5129. doi: 10.3390/cancers14205129. Cancers (Basel). 2022. PMID: 36291913 Free PMC article.
FSCN1 Promotes Glycolysis and Epithelial-Mesenchymal Transition in Prostate Cancer through a YAP/TAZ Signaling Pathway.
Li M, Gao Z, Ding H, Wang Z, Mu H, Zhang L, Wei J, Ma Z. Li M, et al. Among authors: ma z. Evid Based Complement Alternat Med. 2022 Jun 29;2022:6245647. doi: 10.1155/2022/6245647. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Oct 4;2023:9870758. doi: 10.1155/2023/9870758. PMID: 35815268 Free PMC article. Retracted.
15,610 results
You have reached the last available page of results. Please see the User Guide for more information.